Lv1
20 积分 2025-06-20 加入
Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors
27天前
已完结
NRG1 fusions：The potential targeted treatment in non-small cell lung cancer(NSCLC)
1个月前
已完结
NRG1 Fusions: The New Kid on the Block
1个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已完结
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
2个月前
已完结
Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non–Small Cell Lung Cancer (ZEAL-1L)
2个月前
已完结
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
2个月前
已完结
Durvalumab: A Review in Limited-Stage Small Cell Lung Cancer
3个月前
已完结
Advances in Immunotherapy and Chemoradiotherapy Combination for Limited-Stage Small-Cell Lung Cancer: Current Landscape and Future Frontiers
3个月前
已完结
Overcoming Primary and Acquired Resistance to Immunotherapy in Non–Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging Strategies
3个月前
已完结
皖公网安备34019202002308
